Insights

Strategic licensing Ablexis focuses on licensing its AlivaMab Mouse technology to biopharma and academic partners, with a track record of multi-target collaborations and licensing deals, suggesting strong opportunities for outbound partnerships and co-development arrangements with larger pharma and CROs.

Expanded capabilities The launch of AlivaMab Mouse-NGX expands diversity and antigen-specific antibody options, signaling a push into more complex therapeutic modalities and expanded target spaces that can be presented to potential customers seeking advanced discovery platforms.

Integrated services Through its sister company AlivaMab Biologics and the established AlivaMab Discovery Services, Ablexis offers end-to-end discovery and engineering services, providing a one-stop solution for clients looking to outsource antibody discovery and optimization.

Global collaborations Past partnerships with Almirall, Zai Lab, Memorial Sloan Kettering, and Deerfield indicate a proven model for pursuing multinational pharma, biotech, and academic collaborations, suggesting a repeatable approach for entering new regional markets.

Financials & scale With modest revenue and a $12M funding base, Ablexis appears to be in growth mode with room for expansion through licensing deals, expanded services, and joint ventures, aligning with partners seeking scalable, capital-efficient collaboration opportunities.

Similar companies to Ablexis, LLC

Ablexis, LLC Tech Stack

Ablexis, LLC uses 8 technology products and services including Open Graph, WordPress, MySQL, and more. Explore Ablexis, LLC's tech stack below.

  • Open Graph
    Content Management System
  • Content Management System
  • MySQL
    Database
  • E-commerce
  • Marionette.js
    Javascript Frameworks
  • Underscore.js
    Javascript Libraries
  • PWA
    Miscellaneous

Media & News

Ablexis, LLC's Email Address Formats

Ablexis, LLC uses at least 2 email formats:
Ablexis, LLC Email FormatsExamplePercentage
LFirst@ablexis.comDJohn@ablexis.com
67%
FLast@ablexis.comJDoe@ablexis.com
33%

Frequently Asked Questions

What is Ablexis, LLC's phone number?

Minus sign iconPlus sign icon
You can contact Ablexis, LLC's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Ablexis, LLC's official website and social media links?

Minus sign iconPlus sign icon
Ablexis, LLC's official website is ablexis.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Ablexis, LLC generate?

Minus sign iconPlus sign icon
As of October 2026, Ablexis, LLC's annual revenue is estimated to be <$1M.

What is Ablexis, LLC's SIC code and NAICS code?

Minus sign iconPlus sign icon
Ablexis, LLC's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Ablexis, LLC have currently?

Minus sign iconPlus sign icon
As of October 2026, Ablexis, LLC has approximately 1 employees across 1 continents, including North America. Key team members include Senior Research Scientist: D. D., Resident Advisor/Molecular Biology: S. H. and Director Of Research Uperatioris: J. L. Explore Ablexis, LLC's employee directory with LeadIQ.

What industry does Ablexis, LLC belong to?

Minus sign iconPlus sign icon
Ablexis, LLC operates in the Pharmaceutical Manufacturing industry.

What technology does Ablexis, LLC use?

Minus sign iconPlus sign icon
Ablexis, LLC's tech stack includes Open Graph, WordPress, MySQL, Shopify, Google Workspace, Marionette.js, Underscore.js and PWA.

What is Ablexis, LLC's email format?

Minus sign iconPlus sign icon
Ablexis, LLC's email format typically follows the pattern of LFirst@ablexis.com. Find more Ablexis, LLC email formats with LeadIQ.

How much funding has Ablexis, LLC raised to date?

Minus sign iconPlus sign icon
As of October 2026, Ablexis, LLC has raised $12M in funding. The last funding round occurred on Jun 02, 2010 for $12M.

When was Ablexis, LLC founded?

Minus sign iconPlus sign icon
Ablexis, LLC was founded in 2009.
Ablexis, LLC logo

Ablexis, LLC

Pharmaceutical ManufacturingCalifornia, United States0-1 Employees

Ablexis, LLC, based in San Diego, California, develops and licenses the AlivaMab Mouse platform to support human antibody discovery. The platform uses genetically engineered mouse lines designed to yield human antibodies with broad diversity, high affinity, and favorable developability properties, suitable for multiple formats such as IgG, multispecifics, antibody-drug conjugates, CARs, and TCRm.

Its customers include the world's largest pharmaceutical companies, biotechs, and leading academic institutions. Many partners access the platform through Ablexis' sister company, AlivaMab Biologics, which offers related discovery and protein sciences services. In September 2025, Ablexis announced the launch of AlivaMab Mouse-NGX, a next-generation suite that expands both the number and diversity of human variable regions while preserving desirable developability properties.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2009
Employees
0-1

Section iconFunding & Financials

  • $12M

    Ablexis, LLC has raised a total of $12M of funding over 1 rounds. Their latest funding round was raised on Jun 02, 2010 in the amount of $12M as a Series A.

  • <$1M

    Ablexis, LLC's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.